Basis of Presentation (Tables)

3 Months Ended

Mar. 31, 2022

Basis of Presentation

Schedule of effect of changes on actual stock-based compensation expense

	Q1-2021
Additional Paid-in Capital	Increase of $2,512,007
Research and Development Expense	Increase of $125,391
Sales and Marketing	Increase of $62,696
General and Administrative	Increase of $2,323,920
Net Loss	Increase of $2,512,007
Loss per Share	Increase of $0.05